indirubin has been researched along with Experimental Hepatoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bach, S; Blondel, M; Denison, M; Elbi, C; Ffrench, M; Greengard, P; Hager, GL; Han, D; Knockaert, M; Leost, M; Magiatis, P; Meijer, L; Nagy, SR; Polychronopoulos, P; Ryan, XP; Skaltsounis, L | 1 |
1 other study(ies) available for indirubin and Experimental Hepatoma
Article | Year |
---|---|
Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins.
Topics: Animals; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Drug Screening Assays, Antitumor; G1 Phase; Growth Inhibitors; Humans; Indoles; Ligands; Liver Neoplasms, Experimental; Mice; Polychlorinated Dibenzodioxins; Protein Binding; Protein Transport; Receptors, Aryl Hydrocarbon; Structure-Activity Relationship; Tumor Suppressor Proteins | 2004 |